Answers are grounded in this paper and cite their sources.
Retrospective analysis finds RALV-AoPA ECMO improves flow and reduces workload in SCAI stage E patients, suggesting effective intervention.
Background: In Society for Cardiovascular Angiography and Interventions (SCAI) stage E cardiogenic shock, some patients remain unstable despite extracorporeal membrane oxygenation (ECMO) combined with Impella support (ECPELLA). We evaluated the hemodynamic impact of right atrial–left ventricular to aorta–pulmonary artery ECMO (RALV-AoPA ECMO) in ECPELLA-refractory patients. Methods: We retrospectively analyzed 10 patients converted from ECPELLA to RALV-AoPA ECMO since 2022. Hemodynamic parameters were assessed at three predefined time points: during ECPELLA, during RALV-AoPA ECMO, and immediately before biventricular assist device (BiVAD) configuration change (Pre-BiVAD). Biventricular function, mean arterial pressure, heart rate, central venous pressure, mean pulmonary artery pressure, pulmonary artery wedge pressure (PAWP), ECMO flow, and Impella flow were recorded. Pressure–volume loops were computationally reconstructed from measured pressure parameters to estimate left ventricular pressure–volume area as an index of workload. Changes across time points were analyzed using linear regression with patient fixed effects. P<0.05 was considered significant. Results: Following conversion to RALV-AoPA ECMO, ECMO flow significantly increased and PAWP significantly decreased compared with ECPELLA. At Pre-BiVAD, sustained unloading was observed. Estimated pressure–volume area markedly decreased after conversion. Conclusion: Transition to RALV-AoPA ECMO improves systemic flow while reducing left ventricular workload in ECPELLA-refractory SCAI stage E patients.
No takes yet. Share an insight, caveat, or question.
Kimito et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: